Single User License, Team License, Corporate License
Published January 10, 2018
Newborn screening is a health program for screening new born’s right after birth to identify problems that affect child’s health in future. Newborn screening contains series of test which helps to detect the diseases and diagnosis are preventing disability and deaths.
Newborn Screening Market share:
Young Screening market is segmented by test type, product, technology, and geography. On basics of test type, the most substantial percentage is in North America because of the effort to reduce the disabilities of children, and genetic disorders for long-term.
Newborn Screening Market size:
Newborn Screening Market is accounted for USD XX billion in 2017 and expected to grow at a CAGR of X% to reach USD XX billion by 2024.
North America has the highest market for newborn screening market because of the developed infrastructure; the effort made to reduce disabilities; reimbursement policies are raising the demand for the market. During the forecast period, Asia-Pacific is going to have the quick growth in the market.
Newborn Screening Market growth:
The market for newborn screening is driven by factors such as an increase in some newborn diseases, technological development in healthcare, and incidences of critical congenital heart defects in newborns increasing the growth of newborn screening market.
Newborn Screening Market Industrial Analysis:
Newborn Screening Market is segmented by test type, product, technology, and geography. In this categorisation, the growth of the market is driven by test type segment classified by hearing screening test, dry blood spot test, and critical congenital heart disease test is the fastest growing market in the developed and developing countries.
Newborn Screening Market Outlook:
Newborn Screening is primarily used on infants right after their birth to detect the congenital disorders, which turns into mental retardation, dysfunctioning of organs, for instance, in healthcare and growing critical congenital heart defects have further increased the demand for newborn screening and its predominant in North America especially the US.
Newborn Screening Market Trends:
Agilent Technologies Inc. has acquired Oxfordshire, U.K.-based Cobalt Light Systems in July 2017.
PerkinElmer, Inc. agreed to acquire Euroimmun Medical Laboratory Diagnostics AG., in June 2017.
Newborn Screening Market Research Report Includes:
Chapter 1 Introduction
1.1 Executive Summary
1.2 Market Definition
1.3 Scope of the Study
Chapter 2 Research Methodology
2.1 Secondary Research
2.2 Primary Research
2.3 Analytic Tools and Model
2.4 Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5 Expert Validation
2.6 Study Timeline
Chapter 3 Market Analysis
3.1 Industry Value Chain Analysis
3.2 Porter’s Five Analysis
3.2.1 Bargaining Power of Buyers
3.2.2 Bargaining Power of Suppliers
3.2.3 Threats of Substitutes
3.2.4 Threats of New Entrants
3.2.5 Industry Rivalry
3.3 PESTLE Analysis
3.4 SWOT Analysis
3.5 Y-O-Y Analyses
Chapter 4 Market Dynamics
Chapter 5 Market Segmentation Analysis
Chapter 6 Market Segmentation by Test Type
6.1 Hearing Screening Test
6.2 Dry Blood Spot Test
6.3 Critical Congenital Heart Disease (CCHD) Test
Chapter 7 Market Segmentation by Product
7.1 Hearing screening devices and Accessories
7.2 Reagents and assay kits
7.3 Newborn disorder Screening Instruments
7.4 Pulse Oximetry
Chapter 8 Market Segmentation by Technology
8.1 DNA based assay
8.3 Hearing Screen Technology
8.4 Enzymes and Immunoassays
8.5 Tandem Mass Spectrometry
8.6 Pulse Oximetry Technology
Chapter 9 Market Segmentation by Geography
9.1 North America
9.1.2 United States
9.3 Asia Pacific
9.3.5 Australia & New Zealand
9.4 The Middle East and Africa
9.4.2 South Africa
9.4.3 Middle East Countries
9.5 South America
Chapter 10 Competitive Landscape
10.1 Mergers & Acquisitions, Joint Ventures, Collaborations, and Agreements
10.2 Market Share Analysis
10.3 Strategies Adopted By Top Companies
Chapter 11 Company Profiles
11.1 Covidien PLC
11.1.1. Company Overview
11.1.2. Financial Performance
11.1.3. Product Benchmarking
11.1.4. Strategic Initiative
11.2 PerkinElmer Inc.
11.3 Trivitron Healthcare
11.4 Masimo Corporation
11.5 AB Sciex LLC
11.6 Neogen Labs Pvt. Ltd.
11.7 Zen Tech S.A.
11.8 Natus Medical
11.9 Agilent Technologies
11.10 GE Healthcare
11.11 Cardinal Health, Inc.
11.12 Bio-Rad Laboratories
11.13 Medtronic Plc
11.14 Thermo Fisher Scientific, Inc.
11.15 Waters Corporation
Chapter 12 Market Estimates and Forecasting
12.1 Market Estimates and Forecasting 2018-2024(USD Million)
12.1.1 Market Estimation and Forecasting by Test Type 2018-2024 (USD Million)
12.1.2 Market Estimates and Forecasting by Product 2018-2024 (USD Million)
12.1.3 Market Estimates and Forecasting by Technology 2018-2024 (USD Million)
12.1.4 Market Estimates and Forecasting by Geography 2018-2024 (USD Million)
Chapter 13 Market Insights
13.1 Insights of Industry Experts
13.2 Analyst Opinion (Market Understanding)
13.3 Investment Opportunities
Chapter 14 Appendix
14.1 List of Tables
14.2 List of Figures